Seer, Inc. (California) (SEER)
2.19
-0.14
(-6.01%)
USD |
NASDAQ |
Oct 06, 16:00
2.18
-0.01
(-0.46%)
After-Hours: 20:00
Seer Cash from Investing (Quarterly) : -11.47M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -11.47M |
| March 31, 2026 | 18.08M |
| December 31, 2025 | 12.98M |
| September 30, 2025 | 16.60M |
| June 30, 2025 | 7.363M |
| March 31, 2025 | 24.61M |
| December 31, 2024 | 15.85M |
| September 30, 2024 | 26.44M |
| June 30, 2024 | -8.782M |
| March 31, 2024 | 32.36M |
| December 31, 2023 | 6.111M |
| September 30, 2023 | -5.625M |
| June 30, 2023 | 22.94M |
| Date | Value |
|---|---|
| March 31, 2023 | 14.48M |
| December 31, 2022 | -2.711M |
| September 30, 2022 | 2.25M |
| June 30, 2022 | -133.18M |
| March 31, 2022 | 10.92M |
| December 31, 2021 | -87.49M |
| September 30, 2021 | -31.13M |
| June 30, 2021 | -64.15M |
| March 31, 2021 | 11.88M |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | 7.319M |
| March 31, 2020 | 2.952M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Champions Oncology, Inc. | -0.055M |
| Medpace Holdings, Inc. | -23.88M |
| Avantor, Inc. | -37.30M |
| Personalis, Inc. | 38.16M |
| Adaptive Biotechnologies Corp. | -43.48M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.571M |
| Cash from Financing (Quarterly) | -0.205M |
| Free Cash Flow | -44.23M |
| Free Cash Flow Per Share (Quarterly) | -0.1737 |
| Free Cash Flow to Equity (Quarterly) | -8.942M |
| Free Cash Flow to Firm (Quarterly) | -9.58M |
| Free Cash Flow Yield | -36.15% |